Gary S. Gilkeson - Publications

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Cell Biology, Immunology

83/126 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ogunrinde E, Zhou Z, Luo Z, Alekseyenko A, Li QZ, Macedo D, Kamen DL, Oates JC, Gilkeson GS, Jiang W. A link between plasma microbial translocation, microbiome, and autoantibody development in first-degree relatives of systemic lupus erythematosus patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31106972 DOI: 10.1002/art.40935  0.56
2015 Scott JL, Cunningham MA, Naga OS, Wirth JR, Eudaly JG, Gilkeson GS. Estrogen Receptor α Deficiency Modulates TLR Ligand-Mediated PDC-TREM Expression in Plasmacytoid Dendritic Cells in Lupus-Prone Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 26553076 DOI: 10.4049/jimmunol.1500315  0.56
2015 Lu X, Zoller EE, Weirauch MT, Wu Z, Namjou B, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, ... ... Gilkeson GS, et al. Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. American Journal of Human Genetics. 96: 731-9. PMID 25865496 DOI: 10.1016/j.ajhg.2015.03.002  0.56
2014 Vaughn SE, Foley C, Lu X, Patel ZH, Zoller EE, Magnusen AF, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath S, Stevens AM, ... ... Gilkeson GS, et al. Lupus risk variants in the PXK locus alter B-cell receptor internalization. Frontiers in Genetics. 5: 450. PMID 25620976 DOI: 10.3389/fgene.2014.00450  0.56
2014 Cunningham MA, Wirth JR, Freeman LR, Boger HA, Granholm AC, Gilkeson GS. Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. Journal of Neuroinflammation. 11: 171. PMID 25510908 DOI: 10.1186/s12974-014-0171-x  0.56
2014 Svenson J, Cunningham M, Dasgupta S, Gilkeson GS. Estrogen receptor alpha modulates mesangial cell responses to toll-like receptor ligands. The American Journal of the Medical Sciences. 348: 492-500. PMID 25343264 DOI: 10.1097/MAJ.0000000000000339  0.36
2014 Sato S, Lennard Richard M, Brandon D, Jones Buie JN, Oates JC, Gilkeson GS, Zhang XK. A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression. Arthritis & Rheumatology (Hoboken, N.J.). 66: 3436-44. PMID 25155007 DOI: 10.1002/art.38818  0.56
2014 Guthridge JM, Lu R, Sun H, Sun C, Wiley GB, Dominguez N, Macwana SR, Lessard CJ, Kim-Howard X, Cobb BL, Kaufman KM, Kelly JA, Langefeld CD, Adler AJ, Harley IT, ... ... Gilkeson GS, et al. Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. American Journal of Human Genetics. 94: 586-98. PMID 24702955 DOI: 10.1016/j.ajhg.2014.03.008  0.56
2013 Wang D, Zhang H, Liang J, Li X, Feng X, Wang H, Hua B, Liu B, Lu L, Gilkeson GS, Silver RM, Chen W, Shi S, Sun L. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplantation. 22: 2267-77. PMID 24388428 DOI: 10.3727/096368911X582769  0.56
2013 Sakurai D, Zhao J, Deng Y, Kelly JA, Brown EE, Harley JB, Bae SC, AlarcÏŒn-Riquelme ME, Edberg JC, Kimberly RP, Ramsey-Goldman R, Petri MA, Reveille JD, Vilá LM, ... ... Gilkeson GS, et al. Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. Plos Genetics. 9: e1003870. PMID 24130510 DOI: 10.1371/journal.pgen.1003870  0.56
2013 Caster DJ, Korte EA, Nanda SK, McLeish KR, Oliver RK, G'sell RT, Sheehan RM, Freeman DW, Coventry SC, Kelly JA, Guthridge JM, James JA, Sivils KL, Alarcon-Riquelme ME, Scofield RH, ... ... Gilkeson GS, et al. ABIN1 dysfunction as a genetic basis for lupus nephritis. Journal of the American Society of Nephrology : Jasn. 24: 1743-54. PMID 23970121 DOI: 10.1681/ASN.2013020148  0.56
2013 Namjou B, Kim-Howard X, Sun C, Adler A, Chung SA, Kaufman KM, Kelly JA, Glenn SB, Guthridge JM, Scofield RH, Kimberly RP, Brown EE, Alarcón GS, Edberg JC, Kim JH, ... ... Gilkeson GS, et al. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. Plos One. 8: e69404. PMID 23950893 DOI: 10.1371/journal.pone.0069404  0.56
2013 Manku H, Langefeld CD, Guerra SG, Malik TH, Alarcon-Riquelme M, Anaya JM, Bae SC, Boackle SA, Brown EE, Criswell LA, Freedman BI, Gaffney PM, Gregersen PA, Guthridge JM, Han SH, ... ... Gilkeson GS, et al. Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4. Plos Genetics. 9: e1003554. PMID 23874208 DOI: 10.1371/journal.pgen.1003554  0.56
2013 Gilkeson GS, Mashmoushi AK, Ruiz P, Caza TN, Perl A, Oates JC. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. Plos One. 8: e64650. PMID 23741359 DOI: 10.1371/journal.pone.0064650  0.56
2013 Ramos PS, Oates JC, Kamen DL, Williams AH, Gaffney PM, Kelly JA, Kaufman KM, Kimberly RP, Niewold TB, Jacob CO, Tsao BP, Alarcón GS, Brown EE, Edberg JC, Petri MA, ... ... Gilkeson GS, et al. Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry. The Journal of Rheumatology. 40: 842-9. PMID 23637325 DOI: 10.3899/jrheum.120989  0.56
2013 Deng Y, Zhao J, Sakurai D, Kaufman KM, Edberg JC, Kimberly RP, Kamen DL, Gilkeson GS, Jacob CO, Scofield RH, Langefeld CD, Kelly JA, Ramsey-Goldman R, Petri MA, Reveille JD, et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. Plos Genetics. 9: e1003336. PMID 23468661 DOI: 10.1371/journal.pgen.1003336  0.56
2013 Molineros JE, Maiti AK, Sun C, Looger LL, Han S, Kim-Howard X, Glenn S, Adler A, Kelly JA, Niewold TB, Gilkeson GS, Brown EE, Alarcón GS, Edberg JC, Petri M, et al. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. Plos Genetics. 9: e1003222. PMID 23441136 DOI: 10.1371/journal.pgen.1003222  0.56
2013 Baker DA, Eudaly J, Smith CD, Obeid LM, Gilkeson GS. Impact of sphingosine kinase 2 deficiency on the development of TNF-alpha-induced inflammatory arthritis. Rheumatology International. 33: 2677-81. PMID 23011090 DOI: 10.1007/s00296-012-2493-2  0.56
2013 Kaufman KM, Zhao J, Kelly JA, Hughes T, Adler A, Sanchez E, Ojwang JO, Langefeld CD, Ziegler JT, Williams AH, Comeau ME, Marion MC, Glenn SB, Cantor RM, Grossman JM, ... ... Gilkeson GS, et al. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Annals of the Rheumatic Diseases. 72: 437-44. PMID 22904263 DOI: 10.1136/annrheumdis-2012-201851  0.56
2012 Bruner BF, Guthridge JM, Lu R, Vidal G, Kelly JA, Robertson JM, Kamen DL, Gilkeson GS, Neas BR, Reichlin M, Scofield RH, Harley JB, James JA. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis and Rheumatism. 64: 3677-86. PMID 23112091 DOI: 10.1002/art.34651  0.56
2012 Lu R, Robertson JM, Bruner BF, Guthridge JM, Neas BR, Nath SK, Kelly JA, Moser Sivils KL, Chakravarty EF, Kamen DL, Gilkeson GS, Wallace DJ, Weisman MH, Scofield RH, Harley JB, et al. Multiple Autoantibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a Large, Ethnically Diverse SLE Patient Cohort. Autoimmune Diseases. 2012: 819634. PMID 22988489 DOI: 10.1155/2012/819634  0.56
2012 Sánchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA, Langefeld CD, Williams AH, Ziegler JT, Comeau ME, Marion MC, García-De La Torre I, Maradiaga-Ceceña MA, Cardiel MH, Esquivel-Valerio JA, Rodriguez-Amado J, ... ... Gilkeson GS, et al. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis and Rheumatism. 64: 3687-94. PMID 22886787 DOI: 10.1002/art.34650  0.56
2012 Adrianto I, Wang S, Wiley GB, Lessard CJ, Kelly JA, Adler AJ, Glenn SB, Williams AH, Ziegler JT, Comeau ME, Marion MC, Wakeland BE, Liang C, Kaufman KM, Guthridge JM, ... ... Gilkeson GS, et al. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis and Rheumatism. 64: 3695-705. PMID 22833143 DOI: 10.1002/art.34642  0.56
2012 Kim K, Brown EE, Choi CB, Alarcón-Riquelme ME, Kelly JA, Glenn SB, Ojwang JO, Adler A, Lee HS, Boackle SA, Criswell LA, Alarcón GS, Edberg JC, Stevens AM, ... ... Gilkeson GS, et al. Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Annals of the Rheumatic Diseases. 71: 1809-14. PMID 22523428 DOI: 10.1136/annrheumdis-2011-201110  0.56
2012 Lessard CJ, Adrianto I, Ice JA, Wiley GB, Kelly JA, Glenn SB, Adler AJ, Li H, Rasmussen A, Williams AH, Ziegler J, Comeau ME, Marion M, Wakeland BE, Liang C, ... ... Gilkeson GS, et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. American Journal of Human Genetics. 90: 648-60. PMID 22464253 DOI: 10.1016/j.ajhg.2012.02.023  0.56
2012 Namjou B, Choi CB, Harley IT, Alarcón-Riquelme ME, Kelly JA, Glenn SB, Ojwang JO, Adler A, Kim K, Gallant CJ, Boackle SA, Criswell LA, Kimberly RP, Brown EE, ... ... Gilkeson GS, et al. Evaluation of TRAF6 in a large multiancestral lupus cohort. Arthritis and Rheumatism. 64: 1960-9. PMID 22231568 DOI: 10.1002/art.34361  0.56
2012 Hughes T, Adler A, Merrill JT, Kelly JA, Kaufman KM, Williams A, Langefeld CD, Gilkeson GS, Sanchez E, Martin J, Boackle SA, Stevens AM, Alarcón GS, Niewold TB, Brown EE, et al. Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 71: 694-9. PMID 22110124 DOI: 10.1136/annrheumdis-2011-200385  0.56
2012 Niewold TB, Kelly JA, Kariuki SN, Franek BS, Kumar AA, Kaufman KM, Thomas K, Walker D, Kamp S, Frost JM, Wong AK, Merrill JT, Alarcón-Riquelme ME, Tikly M, Ramsey-Goldman R, ... ... Gilkeson GS, et al. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 71: 463-8. PMID 22088620 DOI: 10.1136/annrheumdis-2011-200463  0.56
2012 Hughes T, Adler A, Kelly JA, Kaufman KM, Williams AH, Langefeld CD, Brown EE, Alarcón GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Boackle SA, Stevens AM, Reveille JD, ... ... Gilkeson GS, et al. Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. Arthritis and Rheumatism. 64: 485-92. PMID 21952918 DOI: 10.1002/art.33354  0.56
2011 Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis Research & Therapy. 13: 250. PMID 22192660 DOI: 10.1186/ar3528  0.36
2011 Baker DA, Obeid LM, Gilkeson GS. Impact of sphingosine kinase on inflammatory pathways in fibroblast-like synoviocytes. Inflammation & Allergy Drug Targets. 10: 464-71. PMID 21864273  0.56
2011 Li P, Cook JA, Gilkeson GS, Luttrell LM, Wang L, Borg KT, Halushka PV, Fan H. Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation. Molecular Immunology. 49: 64-74. PMID 21855149 DOI: 10.1016/j.molimm.2011.07.021  0.56
2011 Sánchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD, Brown EE, Alarcón GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Vilá LM, Merrill JT, ... ... Gilkeson GS, et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis and Rheumatism. 63: 3493-501. PMID 21792837 DOI: 10.1002/art.30563  0.56
2011 Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, Niewold TB, Kamen DL, Gilkeson GS, Ziegler JT, Langefeld CD, Alarcón GS, Edberg JC, Ramsey-Goldman R, Petri M, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 70: 1752-7. PMID 21719445 DOI: 10.1136/ard.2011.154104  0.56
2011 Tan W, Sunahori K, Zhao J, Deng Y, Kaufman KM, Kelly JA, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Bae SC, Lee JH, Lee JS, Chang DM, ... ... Gilkeson GS, et al. Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis and Rheumatism. 63: 2755-63. PMID 21590681 DOI: 10.1002/art.30452  0.56
2011 Hughes T, Kim-Howard X, Kelly JA, Kaufman KM, Langefeld CD, Ziegler J, Sanchez E, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Martín J, Brown EE, Vilá LM, ... ... Gilkeson GS, et al. Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. Arthritis and Rheumatism. 63: 1689-97. PMID 21425124 DOI: 10.1002/art.30320  0.56
2011 Adrianto I, Wen F, Templeton A, Wiley G, King JB, Lessard CJ, Bates JS, Hu Y, Kelly JA, Kaufman KM, Guthridge JM, Alarcón-Riquelme ME, Anaya JM, Bae SC, ... ... Gilkeson GS, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nature Genetics. 43: 253-8. PMID 21336280 DOI: 10.1038/ng.766  0.56
2011 Lessard CJ, Adrianto I, Kelly JA, Kaufman KM, Grundahl KM, Adler A, Williams AH, Gallant CJ, Anaya JM, Bae SC, Boackle SA, Brown EE, Chang DM, Criswell LA, ... ... Gilkeson GS, et al. Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. American Journal of Human Genetics. 88: 83-91. PMID 21194677 DOI: 10.1016/j.ajhg.2010.11.014  0.56
2011 Oates JC, Halushka PV, Hutchison FN, Ruiz P, Gilkeson GS. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. The American Journal of the Medical Sciences. 341: 101-5. PMID 20924284 DOI: 10.1097/MAJ.0b013e3181f56d2c  0.56
2011 Webb R, Kelly JA, Somers EC, Hughes T, Kaufman KM, Sanchez E, Nath SK, Bruner G, Alarcón-Riquelme ME, Gilkeson GS, Kamen DL, Richardson BC, Harley JB, Sawalha AH. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Annals of the Rheumatic Diseases. 70: 151-6. PMID 20881011 DOI: 10.1136/ard.2010.141697  0.56
2011 Rasmussen A, Sevier S, Kelly JA, Glenn SB, Aberle T, Cooney CM, Grether A, James E, Ning J, Tesiram J, Morrisey J, Powe T, Drexel M, Daniel W, Namjou B, ... ... Gilkeson GS, et al. The lupus family registry and repository. Rheumatology (Oxford, England). 50: 47-59. PMID 20864496 DOI: 10.1093/rheumatology/keq302  0.56
2010 Morris EE, Amria MY, Kistner-Griffin E, Svenson JL, Kamen DL, Gilkeson GS, Nowling TK. A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis. Arthritis Research & Therapy. 12: R212. PMID 21087477 DOI: 10.1186/ar3189  0.44
2010 Harley IT, Niewold TB, Stormont RM, Kaufman KM, Glenn SB, Franek BS, Kelly JA, Kilpatrick JR, Hutchings D, Divers J, Bruner GR, Edberg JC, McGwin G, Petri MA, Ramsey-Goldman R, ... ... Gilkeson GS, et al. The role of genetic variation near interferon-kappa in systemic lupus erythematosus. Journal of Biomedicine & Biotechnology. 2010. PMID 20706608 DOI: 10.1155/2010/706825  0.56
2010 Baker DA, Barth J, Chang R, Obeid LM, Gilkeson GS. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis. Journal of Immunology (Baltimore, Md. : 1950). 185: 2570-9. PMID 20644167 DOI: 10.4049/jimmunol.1000644  0.56
2010 Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, Collins CE, Gilkeson GS, Diamond B, Hardin JA. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. Plos One. 5: e9193. PMID 20169063 DOI: 10.1371/journal.pone.0009193  0.56
2009 Webb R, Merrill JT, Kelly JA, Sestak A, Kaufman KM, Langefeld CD, Ziegler J, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Alarcón GS, Vilá LM, Alarcón-Riquelme ME, ... ... Gilkeson GS, et al. A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis and Rheumatism. 60: 2402-7. PMID 19644854 DOI: 10.1002/art.24658  0.56
2009 Sekine H, Ferreira RC, Pan-Hammarström Q, Hammarström L, Gilkeson GS, Behrens TW. Comment on "Reassessment of the role of mut S homolog 5 in Ig class switch recombination shows lack of involvement in cis- and trans-switching". Journal of Immunology (Baltimore, Md. : 1950). 182: 4495-6; author reply. PMID 19342619 DOI: 10.4049/jimmunol.0990026  0.56
2009 Namjou B, Sestak AL, Armstrong DL, Zidovetzki R, Kelly JA, Jacob N, Ciobanu V, Kaufman KM, Ojwang JO, Ziegler J, Quismorio FP, Reiff A, Myones BL, Guthridge JM, Nath SK, ... ... Gilkeson GS, et al. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis and Rheumatism. 60: 1085-95. PMID 19333953 DOI: 10.1002/art.24387  0.56
2009 Webb R, Wren JD, Jeffries M, Kelly JA, Kaufman KM, Tang Y, Frank MB, Merrill J, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Alarcón GS, Vilá LM, ... ... Gilkeson GS, et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 60: 1076-84. PMID 19333917 DOI: 10.1002/art.24360  0.56
2009 Jacob CO, Zhu J, Armstrong DL, Yan M, Han J, Zhou XJ, Thomas JA, Reiff A, Myones BL, Ojwang JO, Kaufman KM, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Silverman E, ... ... Gilkeson GS, et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America. 106: 6256-61. PMID 19329491 DOI: 10.1073/pnas.0901181106  0.56
2009 Campbell R, Cooper GS, Gilkeson GS. The impact of systemic lupus erythematosus on employment. The Journal of Rheumatology. 36: 2470-5. PMID 19273454 DOI: 10.3899/jrheum.080586  0.56
2009 Snider AJ, Kawamori T, Bradshaw SG, Orr KA, Gilkeson GS, Hannun YA, Obeid LM. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 143-52. PMID 18815359 DOI: 10.1096/fj.08-118109  0.56
2008 Njoku C, Self SE, Ruiz P, Hofbauer AF, Gilkeson GS, Oates JC. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene Journal of Investigative Medicine. 56: 911-919. PMID 18797415  0.56
2008 Reilly CM, Thomas M, Gogal R, Olgun S, Santo A, Sodhi R, Samy ET, Peng SL, Gilkeson GS, Mishra N. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice Journal of Autoimmunity. 31: 123-130. PMID 18650065 DOI: 10.1016/j.jaut.2008.04.020  0.56
2008 Zhang XK, Moussa O, Larue A, Bradshaw S, Molano I, Spyropoulos DD, Gilkeson GS, Watson DK. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice Journal of Immunology. 181: 1644-1654. PMID 18641300  0.56
2008 Svenson JL, EuDaly J, Ruiz P, Korach KS, Gilkeson GS. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clinical Immunology (Orlando, Fla.). 128: 259-68. PMID 18514033 DOI: 10.1016/j.clim.2008.03.508  0.44
2008 Kamen DL, Barron M, Parker TM, Shaftman SR, Bruner GR, Aberle T, James JA, Scofield RH, Harley JB, Gilkeson GS. Autoantibody prevalence and lupus characteristics in a unique African American population. Arthritis and Rheumatism. 58: 1237-47. PMID 18438839 DOI: 10.1002/art.23416  0.56
2008 Campbell R, Cooper GS, Gilkeson GS. Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: mortality risk and quality of life early in the course of disease. Arthritis and Rheumatism. 59: 458-64. PMID 18383420 DOI: 10.1002/art.23539  0.56
2008 Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicological Sciences : An Official Journal of the Society of Toxicology. 104: 144-54. PMID 18359764 DOI: 10.1093/toxsci/kfn059  0.56
2008 Han S, Guthridge JM, Harley IT, Sestak AL, Kim-Howard X, Kaufman KM, Namjou B, Deshmukh H, Bruner G, Espinoza LR, Gilkeson GS, Harley JB, James JA, Nath SK. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction. Plos One. 3: e0001757. PMID 18335026 DOI: 10.1371/journal.pone.0001757  0.56
2008 Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP, Alarcón-Riquelme ME, James JA, Vyse TJ, Gilkeson GS, Choi CB, Scofield RH, Bae SC, Nath SK, Harley JB. Common variants within MECP2 confer risk of systemic lupus erythematosus. Plos One. 3: e1727. PMID 18320046 DOI: 10.1371/journal.pone.0001727  0.56
2008 Hughes LB, Morrison D, Kelley JM, Padilla MA, Vaughan LK, Westfall AO, Dwivedi H, Mikuls TR, Holers VM, Parrish LA, Alarcón GS, Conn DL, Jonas BL, Callahan LF, Smith EA, ... Gilkeson GS, et al. The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis and Rheumatism. 58: 349-58. PMID 18240241 DOI: 10.1002/art.23166  0.56
2008 Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, Gilkeson GS, Chen W, Zhu C, McEver RP, Kimberly RP, Alarcón-Riquelme ME, Vyse TJ, Li QZ, Wakeland EK, Merrill JT, et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nature Genetics. 40: 152-4. PMID 18204448 DOI: 10.1038/ng.71  0.56
2008 Harley JB, Alarcón-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD, Nath SK, Guthridge JM, Cobb BL, Mirel DB, Marion MC, ... ... Gilkeson GS, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genetics. 40: 204-10. PMID 18204446 DOI: 10.1038/ng.81  0.56
2008 Oates JC, Shaftman SR, Self SE, Gilkeson GS. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis and Rheumatism. 58: 263-72. PMID 18163495 DOI: 10.1002/art.23153  0.56
2008 Nowling TK, Fulton JD, Chike-Harris K, Gilkeson GS. Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes. Molecular Immunology. 45: 1-12. PMID 17606295 DOI: 10.1016/j.molimm.2007.05.018  0.36
2007 Oates JC, Farrelly LW, Hofbauer AF, Wang W, Gilkeson GS. Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients Arthritis and Rheumatism. 56: 3738-3747. PMID 17968874 DOI: 10.1002/art.22955  0.56
2007 Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ. Absence of functional alternative complement pathway alleviates lupus cerebritis. European Journal of Immunology. 37: 1691-701. PMID 17523212 DOI: 10.1002/eji.200636638  0.56
2007 Lenderink AM, Liegel K, Ljubanović D, Coleman KE, Gilkeson GS, Holers VM, Thurman JM. The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy American Journal of Physiology - Renal Physiology. 293. PMID 17522263 DOI: 10.1152/ajprenal.00403.2006  0.56
2007 Sekine H, Ferreira RC, Pan-Hammarström Q, Graham RR, Ziemba B, de Vries SS, Liu J, Hippen K, Koeuth T, Ortmann W, Iwahori A, Elliott MK, Offer S, Skon C, Du L, ... ... Gilkeson GS, et al. Role for Msh5 in the regulation of Ig class switch recombination. Proceedings of the National Academy of Sciences of the United States of America. 104: 7193-8. PMID 17409188 DOI: 10.1073/pnas.0700815104  0.56
2007 Miwa T, Maldonado MA, Zhou L, Yamada K, Gilkeson GS, Eisenberg RA, Song WC. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. The American Journal of Pathology. 170: 1258-66. PMID 17392165 DOI: 10.2353/ajpath.2007.060601  0.56
2006 Nowling TK, Gilkeson GS. Regulation of Fli1 gene expression and lupus. Autoimmunity Reviews. 5: 377-82. PMID 16890890 DOI: 10.1016/j.autrev.2005.10.005  0.36
2006 Oates JC, Gilkeson GS. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clinical Immunology (Orlando, Fla.). 121: 243-50. PMID 16861040 DOI: 10.1016/j.clim.2006.06.001  0.56
2006 Qing X, Zavadil J, Crosby MB, Hogarth MP, Hahn BH, Mohan C, Gilkeson GS, Bottinger EP, Putterman C. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis and Rheumatism. 54: 2198-210. PMID 16804897 DOI: 10.1002/art.21934  0.56
2006 Reilly CM, Olgun S, Goodwin D, Gogal RM, Santo A, Romesburg JW, Ahmed SA, Gilkeson GS. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice European Journal of Immunology. 36: 1296-1308. PMID 16541466 DOI: 10.1002/eji.200535245  0.56
2006 Crosby MB, Zhang J, Nowling TM, Svenson JL, Nicol CJ, Gonzalez FJ, Gilkeson GS. Inflammatory modulation of PPAR gamma expression and activity. Clinical Immunology (Orlando, Fla.). 118: 276-83. PMID 16303334 DOI: 10.1016/j.clim.2005.09.018  0.56
2005 Crosby MB, Svenson J, Gilkeson GS, Nowling TK. A novel PPAR response element in the murine iNOS promoter. Molecular Immunology. 42: 1303-10. PMID 15950726 DOI: 10.1016/j.molimm.2004.12.009  0.56
2005 Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis and Rheumatism. 52: 1148-59. PMID 15818712 DOI: 10.1002/art.20997  0.56
2005 Haraldsson MK, dela Paz NG, Kuan JG, Gilkeson GS, Theofilopoulos AN, Kono DH. Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. Journal of Immunology (Baltimore, Md. : 1950). 174: 5065-73. PMID 15814738  0.56
2005 Crosby MB, Svenson JL, Zhang J, Nicol CJ, Gonzalez FJ, Gilkeson GS. Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. The Journal of Pharmacology and Experimental Therapeutics. 312: 69-76. PMID 15356214 DOI: 10.1124/jpet.104.074005  0.56
2004 Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice Kidney International. 65: 129-138. PMID 14675043 DOI: 10.1111/j.1523-1755.2004.00371.x  0.56
2002 Oates JC, Reilly CM, Crosby MB, Gilkeson GS. Peroxisome proliferator-activated receptor γ agonists: Potential use for treating chronic inflammatory diseases Arthritis and Rheumatism. 46: 598-605. PMID 11920394 DOI: 10.1002/art.10052  0.56
2001 Reilly CM, Oates JC, Sudian J, Crosby MB, Halushka PV, Gilkeson GS. Prostaglandin J2 inhibition of mesangial cell iNOS expression Clinical Immunology. 98: 337-345. PMID 11237557 DOI: 10.1006/clim.2000.4985  0.56
Low-probability matches
2019 Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, Kamen DL, Gilkeson GS, Weisman MH, Karp DR, Gaffney PM, Harley JB, Wallace DJ, Norris JM, James JA. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Annals of the Rheumatic Diseases. PMID 31217170 DOI: 10.1136/annrheumdis-2019-215361  0.28
2018 Cunningham MA, Richard ML, Wirth JR, Scott JL, Eudaly J, Ruiz P, Gilkeson GS. Novel mechanism for estrogen receptor alpha modulation of murine lupus. Journal of Autoimmunity. PMID 30416032 DOI: 10.1016/j.jaut.2018.10.011  0.28
2018 Wolf BJ, Ramos PS, Hyer JM, Ramakrishnan V, Gilkeson GS, Hardiman G, Nietert PJ, Kamen DL. An Analytic Approach Using Candidate Gene Selection and Logic Forest to Identify Gene by Environment Interactions (G × E) for Systemic Lupus Erythematosus in African Americans. Genes. 9. PMID 30326636 DOI: 10.3390/genes9100496  0.28
2018 Patel Z, Lu X, Miller D, Forney CR, Lee J, Lynch A, Schroeder C, Parks L, Magnusen AF, Chen X, Pujato M, Maddox A, Zoller EE, Namjou B, Brunner HI, ... ... Gilkeson GS, et al. A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Human Molecular Genetics. PMID 29912393 DOI: 10.1093/hmg/ddy140  0.28
2017 Langefeld CD, Ainsworth HC, Graham DSC, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, ... ... Gilkeson GS, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nature Communications. 8: 16021. PMID 28714469 DOI: 10.1038/ncomms16021  0.28
2017 Zhao J, Ma J, Deng Y, Kelly JA, Kim K, Bang SY, Lee HS, Li QZ, Wakeland EK, Qiu R, Liu M, Guo J, Li Z, Tan W, Rasmussen A, ... ... Gilkeson GS, et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nature Genetics. PMID 28135245 DOI: 10.1038/ng.3782  0.28
2016 Munroe ME, Young KA, Kamen DL, Guthridge JM, Niewold TB, Costenbader KH, Weisman MH, Ishimori ML, Wallace DJ, Gilkeson GS, Karp DR, Harley JB, Norris JM, James JA. Soluble Mediators and Clinical Features Discern Risk of Transitioning to Classified Disease in Relatives of Systemic Lupus Erythematosus Patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27863174 DOI: 10.1002/art.40004  0.28
2016 Young KA, Munroe ME, Guthridge JM, Kamen DL, Niewold TB, Gilkeson GS, Weisman MH, Ishimori ML, Kelly J, Gaffney PM, Sivils KH, Lu R, Wallace DJ, Karp DR, Harley JB, et al. Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 27283331 DOI: 10.1136/annrheumdis-2016-209157  0.28
2016 Deng Y, Zhao J, Sakurai D, Sestak AL, Osadchiy V, Langefeld CD, Kaufman KM, Kelly JA, James JA, Petri MA, Bae SC, Alarcón-Riquelme ME, Alarcón GS, Anaya JM, Criswell LA, ... ... Gilkeson GS, et al. Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production. Annals of the Rheumatic Diseases. PMID 26783109 DOI: 10.1136/annrheumdis-2015-208441  0.28
2015 Liu K, Kurien BT, Zimmerman SL, Kaufman KM, Taft DH, Kottyan LC, Lazaro S, Weaver CA, Ice JA, Adler AJ, Chodosh J, Radfar L, Rasmussen A, Stone DU, Lewis DM, ... ... Gilkeson GS, et al. X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26713507 DOI: 10.1002/art.39560  0.28
2015 Zhao J, Wu H, Langefeld CD, Kaufman KM, Kelly JA, Bae SC, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, James JA, et al. Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus. Clinical Immunology (Orlando, Fla.). PMID 26385092 DOI: 10.1016/j.clim.2015.09.007  0.28
2015 Midgett K, Peden-Adams MM, Gilkeson GS, Kamen DL. In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL-2 production in human T-cells. Journal of Applied Toxicology : Jat. 35: 459-65. PMID 25056757 DOI: 10.1002/jat.3037  0.28
2014 Barnado A, Wheless L, Meyer AK, Gilkeson GS, Kamen DL. Pregnancy outcomes among African-American patients with systemic lupus erythematosus compared with controls. Lupus Science & Medicine. 1: e000020. PMID 25360323 DOI: 10.1136/lupus-2014-000020  0.28
2014 Collins E, Gu F, Qi M, Molano I, Ruiz P, Sun L, Gilkeson GS. Differential efficacy of human mesenchymal stem cells based on source of origin. Journal of Immunology (Baltimore, Md. : 1950). 193: 4381-90. PMID 25274529 DOI: 10.4049/jimmunol.1401636  0.28
2014 Zhao J, Giles BM, Taylor RL, Yette GA, Lough KM, Ng HL, Abraham LJ, Wu H, Kelly JA, Glenn SB, Adler AJ, Williams AH, Comeau ME, Ziegler JT, Marion M, ... ... Gilkeson GS, et al. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Annals of the Rheumatic Diseases. PMID 25180293 DOI: 10.1136/annrheumdis-2014-205584  0.28
2012 Gu F, Molano I, Ruiz P, Sun L, Gilkeson GS. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. Clinical Immunology (Orlando, Fla.). 145: 142-52. PMID 23041504 DOI: 10.1016/j.clim.2012.08.012  0.28
2011 Sekine H, Ruiz P, Gilkeson GS, Tomlinson S. The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition. Molecular Immunology. 49: 317-23. PMID 22000720 DOI: 10.1016/j.molimm.2011.09.015  0.28
2011 Zhao J, Wu H, Khosravi M, Cui H, Qian X, Kelly JA, Kaufman KM, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Adler A, Glenn SB, Alarcón-Riquelme ME, ... ... Gilkeson GS, et al. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. Plos Genetics. 7: e1002079. PMID 21637784 DOI: 10.1371/journal.pgen.1002079  0.28
2011 Sekine H, Kinser TT, Qiao F, Martinez E, Paulling E, Ruiz P, Gilkeson GS, Tomlinson S. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice. Arthritis and Rheumatism. 63: 1076-85. PMID 21452327 DOI: 10.1002/art.30222  0.28
2010 Rohrer B, Long Q, Coughlin B, Renner B, Huang Y, Kunchithapautham K, Ferreira VP, Pangburn MK, Gilkeson GS, Thurman JM, Tomlinson S, Holers VM. A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. Advances in Experimental Medicine and Biology. 703: 137-49. PMID 20711712 DOI: 10.1007/978-1-4419-5635-4_10  0.28
2009 Keil DE, Peden-Adams MM, Wallace S, Ruiz P, Gilkeson GS. Assessment of trichloroethylene (TCE) exposure in murine strains genetically-prone and non-prone to develop autoimmune disease. Journal of Environmental Science and Health. Part a, Toxic/Hazardous Substances & Environmental Engineering. 44: 443-53. PMID 19241258 DOI: 10.1080/10934520902719738  0.28
2008 Anderson E, Nietert PJ, Kamen DL, Gilkeson GS. Ethnic disparities among patients with systemic lupus erythematosus in South Carolina. The Journal of Rheumatology. 35: 819-25. PMID 18381790  0.28
2006 Sekine H, Graham KL, Zhao S, Elliott MK, Ruiz P, Utz PJ, Gilkeson GS. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus. Journal of Immunology (Baltimore, Md. : 1950). 177: 7423-34. PMID 17082662  0.28
2006 Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmunity Reviews. 5: 114-7. PMID 16431339 DOI: 10.1016/j.autrev.2005.05.009  0.28
2016 Cunningham MA, Wirth JR, Scott JL, Eudaly J, Collins EL, Gilkeson GS. Early Ovariectomy Results in Reduced Numbers of CD11c+/CD11b+ Spleen Cells and Impacts Disease Expression in Murine Lupus. Frontiers in Immunology. 7: 31. PMID 26913030 DOI: 10.3389/fimmu.2016.00031  0.24
2014 Cunningham MA, Wirth JR, Naga O, Eudaly J, Gilkeson GS. Estrogen Receptor Alpha Binding to ERE is Required for Full Tlr7- and Tlr9-Induced Inflammation. Soj Immunology. 2. PMID 25061615 DOI: 10.15226/soji.2014.00107  0.24
2019 Craft JE, Crow MK, Diamond B, Elkon KB, Flood J, Fox DA, Gabriel SE, Gilkeson GS, Hahn BH, Hardin JA, Koopman WJ, Lockshin MD, Salmon JE, Seaman WE, Sergent JS, et al. Georgia Abortion Law and our Commitment to Patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31637878 DOI: 10.1002/art.41143  0.12
2008 Peden-Adams MM, Eudaly JG, Lee AM, Miller J, Keil DE, Gilkeson GS. Lifetime exposure to trichloroethylene (TCE) does not accelerate autoimmune disease in MRL +/+ mice. Journal of Environmental Science and Health. Part a, Toxic/Hazardous Substances & Environmental Engineering. 43: 1402-9. PMID 18780217 DOI: 10.1080/10934520802232063  0.04
2018 Wang D, Zhang H, Liang J, Wang H, Hua B, Feng X, Gilkeson GS, Farge D, Shi S, Sun L. A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus. Stem Cell Reports. PMID 29478901 DOI: 10.1016/j.stemcr.2018.01.029  0.01
2016 Scott JL, Wirth JR, EuDaly JG, Gilkeson GS, Cunningham MA. Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease. Clinical Immunology (Orlando, Fla.). PMID 28041989 DOI: 10.1016/j.clim.2016.12.009  0.01
2014 Gu F, Wang D, Zhang H, Feng X, Gilkeson GS, Shi S, Sun L. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clinical Rheumatology. 33: 1611-9. PMID 25119864 DOI: 10.1007/s10067-014-2754-4  0.01
2013 Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, ... ... Gilkeson GS, et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nature Genetics. 45: 690-6. PMID 23583978 DOI: 10.1038/ng.2608  0.01
2012 Tang Y, Ma X, Zhang H, Gu Z, Hou Y, Gilkeson GS, Lu L, Zeng X, Sun L. Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus. Clinical & Developmental Immunology. 2012: 826182. PMID 22966240 DOI: 10.1155/2012/826182  0.01
2012 Cunningham MA, Naga OS, Eudaly JG, Scott JL, Gilkeson GS. Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus. Clinical Immunology (Orlando, Fla.). 144: 1-12. PMID 22659029 DOI: 10.1016/j.clim.2012.04.001  0.01
2010 Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, Hou Y, Zeng X, Gilkeson GS, Sun L. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Annals of the Rheumatic Diseases. 69: 1423-9. PMID 20650877 DOI: 10.1136/ard.2009.123463  0.01
2010 Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, Hua B, Liu B, Ye S, Hu X, Xu W, Zeng X, Hou Y, Gilkeson GS, Silver RM, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis and Rheumatism. 62: 2467-75. PMID 20506343 DOI: 10.1002/art.27548  0.01
2009 Rohrer B, Long Q, Coughlin B, Wilson RB, Huang Y, Qiao F, Tang PH, Kunchithapautham K, Gilkeson GS, Tomlinson S. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Investigative Ophthalmology & Visual Science. 50: 3056-64. PMID 19264882 DOI: 10.1167/iovs.08-2222  0.01
2009 Keil DE, McGuinn WD, Dudley AC, EuDaly JG, Gilkeson GS, Peden-Adams MM. N,N,-diethyl-m-toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice. Toxicological Sciences : An Official Journal of the Society of Toxicology. 108: 110-23. PMID 19141786 DOI: 10.1093/toxsci/kfp001  0.01
2008 Atkinson C, Qiao F, Song H, Gilkeson GS, Tomlinson S. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. Journal of Immunology (Baltimore, Md. : 1950). 180: 1231-8. PMID 18178863  0.01
2007 Rohrer B, Guo Y, Kunchithapautham K, Gilkeson GS. Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage. Investigative Ophthalmology & Visual Science. 48: 5282-9. PMID 17962484 DOI: 10.1167/iovs.07-0282  0.01
2007 Cooper GS, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 57: 993-9. PMID 17665464 DOI: 10.1002/art.22894  0.01
2006 Peden-Adams MM, Eudaly JG, Heesemann LM, Smythe J, Miller J, Gilkeson GS, Keil DE. Developmental immunotoxicity of trichloroethylene (TCE): studies in B6C3F1 mice. Journal of Environmental Science and Health. Part a, Toxic/Hazardous Substances & Environmental Engineering. 41: 249-71. PMID 16484062 DOI: 10.1080/10934520500455289  0.01
2005 Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. The New England Journal of Medicine. 353: 2219-28. PMID 16306519 DOI: 10.1056/NEJMoa043731  0.01
Hide low-probability matches.